BridgeMD
Compares treatment options for Liver Cancer
Official title Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
ClinicalTrials.gov ID: NCT04731558
What this study is testing
What is enoxaparin or tinzaparin or dalteparin?
enoxaparin or tinzaparin or dalteparin is an investigational medicine, being studied as a potential treatment for liver cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Thromboprophylaxis for liver surgery can be commenced either preoperatively or postoperatively. Despite a clear trade-off between thrombosis and bleeding in liver surgery patients, there is no international consensus when thrombosis prophylaxis should be commenced in patients undergoing liver surgery.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patients undergoing liver resection
You likely can't join if
- Patient on anticoagulative medication (heparin, low-molecular weight heparin, warfarin, direct oral anticoagulants) during last month pre-surgery
- Emergency operation (e.g. for trauma or infection)
- Age \< 18 years
- Allergy or other contraindication to planned low-molecular weight heparin
- Inability to give written informed consent
- Liver resection not performed (removed from analyses after randomization)
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Finland
- Kuopio, Finland
- Oulu, Finland
- Tampere, Finland
- Turku, Finland
- Oslo, Norway
- Tromsø, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Finland; Kuopio, Finland; Oulu, Finland; Tampere, Finland; Turku, Finland; Oslo, Norway and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.